Explicit Finance Board of Directors

Get the latest insights into the leadership at Explicit Finance. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Rajesh Nanda Managing Director
Mr. Gopal Bhagwatilal Dave Director
Mr. Pushparaj Vilas Mayekar Director
Mr. Jitendra Bhanushali Director
Mr. Avinash Bhargavram Mainkar Director
Ms. Hetal Bhanushali Director

Explicit Finance Share price

EXPLICITFIN

8.75

0.24 (2.82%)
Last updated on 4 Sep, 2025 | 15:12 IST
BUYSELL
Today's High

8.75

Today's Low

8.75

52 Week Low

5.77

52 Week High

9.98

The current prices are delayed, login to your account for live prices

Explicit Finance FAQs

The board at Explicit Finance consists of experienced professionals, including Mr. Rajesh Nanda , Mr. Gopal Bhagwatilal Dave , and others, overseeing the company’s strategic and corporate governance.

Directors at Explicit Finance are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Rajesh Nanda is the current chairman at Explicit Finance.

Executive directors at Explicit Finance are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Explicit Finance adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Explicit Finance, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.